Purpose: Timeliness of cancer treatment is an important aspect of health care quality. Veterans Affairs Medical Centers (VAMCs) are expected to treat a growing number of patients with cancer. Our objectives were to examine treatment times from diagnosis to first-course therapy for patients with colon and rectal cancers and assess factors associated with pro-longed wait times. Methods: From the VA Central Cancer Registry, patients who underwent colon or rectal resection for cancer from 1998 to 2008 were identified. Time from diagnosis to definitive can-cer-directed therapy was measured, and multivariable regres-sion methods were used to determine predictors of prolonged wait times for colon ( 45 days) and rectal ( 60 days) cancers. Results...
The Veterans Affairs (VA) healthcare system treats approximately 3% of patients with cancer in the U...
Background: Substantial advances in chemotherapy for colorectal cancer (CRC) occurred between 2000 a...
BACKGROUND: Poorer colorectal cancer survival in the UK than in similar countries may be partly due ...
The goals of this study were to evaluate determinants of the time in the medical system until a colo...
BACKGROUND: The aim of this study is to determine whether multidisciplinary team (MDT) meetings alte...
Purpose: Adjuvant chemotherapy (AC) improves survival among patients with colon cancer (CC). Two met...
Objectives: To compare colorectal cancer screening rates in veterans receiving primary care (PC) in ...
ABSTRACT Objective There is concern that patients are waiting too long to be diagnosed with colorec...
textabstractBackground: The Dutch Cancer Society proposed that the interval between diagnosis and st...
Our objective was to examine potential racial differences in CRC care timeliness in the Veterans Aff...
Purpose To evaluate factors affecting the use and delay8 weeks of adjuvant chemotherapy and the impa...
Objective: To evaluate whether prolonged waiting times for colonoscopy in public hospitals could res...
BACKGROUNDS Many studies have highlighted the influence of diagnostic and therapeutic delays on the...
To assess the impact of delay from diagnosis to curative surgery on survival in patients with non-me...
Aim: To investigate the various factors responsible for delays in the diagnosis and treatment of col...
The Veterans Affairs (VA) healthcare system treats approximately 3% of patients with cancer in the U...
Background: Substantial advances in chemotherapy for colorectal cancer (CRC) occurred between 2000 a...
BACKGROUND: Poorer colorectal cancer survival in the UK than in similar countries may be partly due ...
The goals of this study were to evaluate determinants of the time in the medical system until a colo...
BACKGROUND: The aim of this study is to determine whether multidisciplinary team (MDT) meetings alte...
Purpose: Adjuvant chemotherapy (AC) improves survival among patients with colon cancer (CC). Two met...
Objectives: To compare colorectal cancer screening rates in veterans receiving primary care (PC) in ...
ABSTRACT Objective There is concern that patients are waiting too long to be diagnosed with colorec...
textabstractBackground: The Dutch Cancer Society proposed that the interval between diagnosis and st...
Our objective was to examine potential racial differences in CRC care timeliness in the Veterans Aff...
Purpose To evaluate factors affecting the use and delay8 weeks of adjuvant chemotherapy and the impa...
Objective: To evaluate whether prolonged waiting times for colonoscopy in public hospitals could res...
BACKGROUNDS Many studies have highlighted the influence of diagnostic and therapeutic delays on the...
To assess the impact of delay from diagnosis to curative surgery on survival in patients with non-me...
Aim: To investigate the various factors responsible for delays in the diagnosis and treatment of col...
The Veterans Affairs (VA) healthcare system treats approximately 3% of patients with cancer in the U...
Background: Substantial advances in chemotherapy for colorectal cancer (CRC) occurred between 2000 a...
BACKGROUND: Poorer colorectal cancer survival in the UK than in similar countries may be partly due ...